Cannabis Report
Home > Boards > US OTC > Oil/Gas/Natural Energy Production >

AngioSoma Inc. (SOAN)

SOAN RSS Feed
Add SOAN Price Alert      Hide Sticky   Hide Intro
Moderator: BERKSHIRE AGENT , makinezmoney, KOmani, Dr_Q
Search This Board: 
Last Post: 7/18/2018 10:29:23 AM - Followers: 54 - Board type: Free - Posts Today: 0

 




OTCBB: $SOAN





SHARE STRUCTURE







  

AngioSoma, Inc. (http://angiosoma.info/), a Nevada corporation based in Houston, Texas, markets
our Somaceuticals™ line of health supplements. Our innovative supplements cover three industry
segments: nutraceuticals, cosmeceuticals, and pharmaceuticals, all dedicated to improving the mental and
physical wellbeing of men and women.
Alex Blankenship, CEO, has expressed her appreciation for the valuable contribution of AllianceTek,
for developing the marketing strategy as well as the design and creation of our marketing website:
 
www.soma-ceuticals.com

AngioSoma is developing its lead product, a drug candidate called Liprostin TM  for the treatment of peripheral artery
disease, or PAD, which has completed FDA Phase I and three Phase II clinical trials.
We are in discussions with several contract research organizations for completion of our FDA protocol
for Phase III and submission of our new drug application for marketing in the US and its territories.





PERIPHERAL ARTERY DISEASE

http://www.wavy.com/hr-show/peripheral-artery-disease-1/1167005793








 

As of February 14, 2018, 52,084,067 shares of common stock are issued and outstanding.

 


May 14, 2018 News:
 

AngioSoma, Inc. Announces Grant of Patent for Flagship Drug

May 14, 2018 12:13 ET Source: AngioSoma, Inc.

https://globenewswire.com/news-release/2018/05/14/1501937/0/en/AngioSoma-Inc-Announces-Grant-of-Patent-for-Flagship-Drug.html
 

HOUSTON, TX, May 14, 2018 (GLOBE NEWSWIRE) -- AngioSoma, Inc. (OTC: SOAN) is excited to announce that the U.S. Patent Office has agreed to grant our patent application for our flagship pharmaceutical, Liprostin™ that is intended to treat Peripheral Artery Disease, or PAD. 

We are told the market opportunity is significant with 8 million U.S. diagnosed cases of PAD costing $212 - $389 billion annually.  PAD costs exceed diabetes, coronary artery disease and cancers. It is reported that 60% to 70% of diabetics contract peripheral artery disease, often resulting in amputation as treatment.

 



 
 


 
 
CEO : ALEX BLANKENSHIP

https://www.facebook.com/alexkb1225

 




 




 
STOCK CHART



 
Cannabis Report
SOAN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#472  Sticky Note $SOAN: Big News Yesterday.... Liprostin FDA Approval Reg-Firm Selected makinezmoney 06/19/18 10:48:31 AM
#434  Sticky Note AngioSoma, Inc. Announces Grant of Patent for Flagship Drug KOmani 05/16/18 05:55:36 AM
#612   https://www.fda.gov/forpatients/approvals/drugs/ucm405622.htm sharky 07/18/18 10:29:23 AM
#611   Thanks, I saw that when I was going nac109 07/17/18 10:45:42 AM
#610   From June 18th PR: The regulatory firm will sharky 07/17/18 10:40:23 AM
#609   thanks dshade 07/17/18 09:26:49 AM
#608   When are you guys suppose to find out nac109 07/17/18 01:17:04 AM
#607   in time Dahmer 07/16/18 05:59:35 PM
#606   Nice long hold IMO. Phase III news comes sharky 07/16/18 01:41:35 PM
#605   Have a great week ahead ! GS1 07/16/18 01:10:59 AM
#604   ~good work~ FergusVI 07/15/18 07:44:05 PM
#603   hammered down bottom chart needs some insider love here Dahmer 07/15/18 02:19:50 PM
#602   green candle stick for the week will do Dahmer 07/14/18 01:49:54 PM
#601   they need a partner Dahmer 07/14/18 01:44:42 PM
#600   thank you, but why don't they file any Dahmer 07/14/18 01:42:41 PM
#599   They are not transferring patents CEO confirmed it. GS1 07/14/18 11:12:20 AM
#598   company won't sell on 0 interest, shows they Dahmer 07/13/18 03:45:12 PM
#597   it is quite odd and never had a Dahmer 07/13/18 10:48:14 AM
#596   I just posted that snippet this week...it's strange FergusVI 07/13/18 10:01:17 AM
#595   I see no insider ownership of this stock. kindo 07/13/18 07:56:22 AM
#594   This statement from the May 14th PR has kindo 07/13/18 07:41:57 AM
#593   yup strange trading it was company update about GS1 07/12/18 08:01:51 PM
#592   nothing weird today but I'm pretty sure this Dahmer 07/12/18 05:59:29 PM
#591   sar flip next 2 weeks Dahmer 07/12/18 05:44:32 PM
#590   hammered bottom unlike POS INND, they don't sell Dahmer 07/12/18 01:06:46 PM
#589   Agree, they are now set up for revenue FergusVI 07/12/18 12:52:14 PM
#588   never have i seen a stock about to Dahmer 07/12/18 12:46:39 PM
#587   sounds like it, they need to work on Dahmer 07/12/18 10:22:07 AM
#586   Pr sounds like the start of a rollout wealthmoney 07/12/18 05:18:45 AM
#585   indicates note conversion should be done now need GS1 07/12/18 12:38:47 AM
#584   no T trades yet again. Dahmer 07/12/18 12:15:06 AM
#583   desperate to gain momo don't run QB tickers Dahmer 07/11/18 04:10:50 PM
#582   Wth was that news lol jeeez TOADPALEFACE 07/11/18 03:22:02 PM
#581   that was waste of money Natural Trader 07/11/18 03:06:01 PM
#580   I sent email to IR, and told them stocks2watch 07/11/18 03:02:00 PM
#579   it was a poor pump attempt , volume faded Dahmer 07/11/18 02:47:55 PM
#578   Stock goes down on this news.This is stocks2watch 07/11/18 02:44:59 PM
#577   AngioSoma Unveils New Logo and Brand Identity Rainer 07/11/18 02:36:36 PM
#576   News out S3lfMade 07/11/18 02:34:27 PM
#575   sounds weird so, someone else took his place, Dahmer 07/11/18 02:11:01 PM
#574   What do you make of this line in FergusVI 07/11/18 01:34:50 PM
#573   last run went to .12 may 14th on Natural Trader 07/11/18 01:13:30 PM
#572   Would have thought with this getting FDA approval stocks2watch 07/11/18 01:11:09 PM
#571   can go green no problem need that burst Dahmer 07/11/18 01:02:06 PM
#570   No bid support so one small whack can stockyard10 07/11/18 12:13:36 PM
#569   Took a starter ~~ FergusVI 07/11/18 11:55:09 AM
#568   We've had 168,000 buys and only 10,000 in stocks2watch 07/11/18 11:41:26 AM
#566   Agree looks ready bet we see some filings BERKSHIRE AGENT 07/11/18 10:27:31 AM
#565   AngioSoma, Inc. (OTC: SOAN) is in discussions to Natural Trader 07/11/18 10:24:21 AM
#564   Is news coming? stocks2watch 07/11/18 10:22:34 AM
#563   SOAN going to make a nice move very soon Natural Trader 07/11/18 10:21:18 AM
#562   Gm All Natural Trader 07/11/18 07:15:11 AM
PostSubject